What if we could diagnose Alzheimer's disease before symptoms started? The hope is, future treatments could then target the disease in its earliest stages, before irreversible brain damage or mental decline has occurred. Research on new strategies for earlier diagnosis is among the most active areas in Alzheimer's science. This is a time of unprecedented promise in the race to end Alzheimer's.
Join us for a Lunch-n-Learn conversation with the Alzheimer's Association Chief Science Officer, Maria C. Carrillo, Ph.D.
Dr. Carrillo sets the strategic vision for the Alzheimer’s Association global research program. She oversees the implementation of the Association’s growing portfolio of research initiatives, including the Alzheimer’s Association International Conference® (AAIC®), the world’s largest and most influential dementia science meeting, and the Research Roundtable, which enables international scientific, industry and government leaders to work together to overcome shared obstacles in Alzheimer’s science and drug development. In addition, Dr. Carrillo manages the World Wide Alzheimer’s Disease Neuroimaging Initiative (WW-ADNI), a multi-country research effort aimed at accelerating the early detection of Alzheimer’s.
Read Dr. Carrillo's bio here
Alzheimer's Association 2021 Facts and Figures
Chicago Finance Exchange332 S. Michigan Avenue, Suite 1032 - #C232Chicago, IL 60604 - 4434312-833-8782Contact us by email: email@example.com